| |
| |
|
| Insider
Information: |
Tarnok Michael P. |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
554,703 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$309,027 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
554,703 |
|
|
| Total
Value |
$309,027 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2015-06-17 |
338,600 |
2008-11-14 |
0 |
Premium* |
|
|
Dyadic International Inc |
DYAI |
Director |
2024-01-03 |
216,103 |
2024-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DYAI |
Dyadic International Inc |
Director |
• • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,174 |
216,103 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2015-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
338,600 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2015-05-06 |
4 |
B |
$9.73 |
$97,300 |
D/D |
10,000 |
328,600 |
2.39 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2014-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
318,600 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
308,600 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2012-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
293,600 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2012-04-05 |
4 |
B |
$1.55 |
$27,125 |
D/D |
17,500 |
278,600 |
2.39 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2011-08-10 |
4 |
B |
$3.10 |
$46,500 |
D/D |
15,000 |
261,100 |
2.39 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2010-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
231,100 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2009-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
216,100 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2009-05-26 |
4 |
B |
$0.46 |
$18,400 |
D/D |
40,000 |
191,100 |
2.39 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Interim CEO |
• • – |
2009-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
151,100 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2008-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
51,100 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2007-11-19 |
4 |
B |
$8.71 |
$9,581 |
D/D |
1,100 |
1,100 |
2.39 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
